258 related articles for article (PubMed ID: 30502116)
1. An insight into medicinal chemistry of anticancer quinoxalines.
Kaushal T; Srivastava G; Sharma A; Singh Negi A
Bioorg Med Chem; 2019 Jan; 27(1):16-35. PubMed ID: 30502116
[TBL] [Abstract][Full Text] [Related]
2. Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity.
El Newahie AM; Ismail NS; Abou El Ella DA; Abouzid KA
Arch Pharm (Weinheim); 2016 May; 349(5):309-26. PubMed ID: 27062086
[TBL] [Abstract][Full Text] [Related]
3. Quinoxaline: An insight into the recent pharmacological advances.
Tariq S; Somakala K; Amir M
Eur J Med Chem; 2018 Jan; 143():542-557. PubMed ID: 29207337
[TBL] [Abstract][Full Text] [Related]
4. Recent Methods for the Synthesis of Quinoxaline Derivatives and their Biological Activities.
Farghaly TA; Alqurashi RM; Masaret GS; Abdulwahab HG
Mini Rev Med Chem; 2024; 24(9):920-982. PubMed ID: 37885112
[TBL] [Abstract][Full Text] [Related]
5. DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF 2,3-DISUBSTITUTED AND FUSED QUINOXALINES AS POTENTIAL ANTICANCER AND ANTIMICROBIAL AGENTS.
Abbas HS; Al-Marhabi ARM; Ammar YA
Acta Pol Pharm; 2017 Mar; 74(2):445-458. PubMed ID: 29624250
[TBL] [Abstract][Full Text] [Related]
6. Quinoxalinone as a Privileged Platform in Drug Development.
Shi L; Hu W; Wu J; Zhou H; Zhou H; Li X
Mini Rev Med Chem; 2018 Feb; 18(5):392-413. PubMed ID: 29090665
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
[TBL] [Abstract][Full Text] [Related]
9. Quinoxaline chemistry. Part 13: 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activity.
Corona P; Vitale G; Loriga M; Paglietti G
Farmaco; 2000 Feb; 55(2):77-86. PubMed ID: 10782376
[TBL] [Abstract][Full Text] [Related]
10. Reusable nano-catalyzed green protocols for the synthesis of quinoxalines: an overview.
Keri RS; Reddy D; Budagumpi S; Adimule V
RSC Adv; 2023 Jun; 13(29):20373-20406. PubMed ID: 37425629
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents.
Rodrigues FA; Bomfim Ida S; Cavalcanti BC; Pessoa Cdo Ó; Wardell JL; Wardell SM; Pinheiro AC; Kaiser CR; Nogueira TC; Low JN; Gomes LR; de Souza MV
Bioorg Med Chem Lett; 2014 Feb; 24(3):934-9. PubMed ID: 24398294
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity.
Sanna P; Carta A; Loriga M; Zanetti S; Sechi L
Farmaco; 1998 Jul; 53(7):455-61. PubMed ID: 9836457
[TBL] [Abstract][Full Text] [Related]
13. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity.
Vitale G; Corona P; Loriga M; Paglietti G
Farmaco; 1998; 53(8-9):594-601. PubMed ID: 10081824
[TBL] [Abstract][Full Text] [Related]
14. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.
El Newahie AMS; Nissan YM; Ismail NSM; Abou El Ella DA; Khojah SM; Abouzid KAM
Molecules; 2019 Mar; 24(6):. PubMed ID: 30934622
[TBL] [Abstract][Full Text] [Related]
16. Sulphonamido-quinoxalines: search for anticancer agent.
Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
[TBL] [Abstract][Full Text] [Related]
17. [Design and synthesis of quinoxaline derivatives and their antitumor activities].
Zhao CH; Chen Y; Ding J; Duan WH
Yao Xue Xue Bao; 2005 Sep; 40(9):814-9. PubMed ID: 16342683
[TBL] [Abstract][Full Text] [Related]
18. Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery.
Pinheiro AC; Mendonça Nogueira TC; de Souza MV
Anticancer Agents Med Chem; 2016; 16(10):1339-52. PubMed ID: 27349448
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
20. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
